PMN — ProMIS Neurosciences Inc.

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About ProMIS Neurosciences Inc.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$10.48
Market Cap$97.3M
Float4.6M
Shares Outstanding9.0M
Price/Sales (TTM)4,016.22
vs. Analyst Target+237.9% to analyst PT
Revenue (TTM)$7,558
Dividend RateNone
Analyst Target Price$35.41 (3 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1,565 -$5.7M -$3.2M -$5.6M
2021 $8,138.7 -$9.7M -$5.8M -$9.3M
2022 $8,138.7 -$18.1M -$21.8M -$17.8M
2023 N/A -$17.5M -$10.4M -$17.8M
2024 N/A $2.8M N/A $2.9M
2025 N/A -$39.7M N/A -$39.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$10.1M
Sep 2025 N/A -$11.6M
Dec 2025 N/A -$10.7M
Mar 2026 N/A -$8.2M

Ownership & Float

Insider Ownership11.9%
Institutional Ownership74.4%
Short Float3.1%
% of All Funds Holding0.27%
Number of Funds Holding22

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$11.53Near-term / short-term trend
Weekly40-Week SMA$11.80Medium-term trend
Weekly80-Week SMA$14.83Cyclical trend (business cycle)
Weekly200-Week SMA$53.98Secular trend (multi-year)
Monthly10-Month SMA$12.02Near-term monthly trend
Monthly20-Month SMA$15.85Medium-term monthly trend
Monthly40-Month SMA$40.29Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$6.80 support 2.71x 3 months ago

Historical Earnings Reactions (54 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.16% 0.00% 22.22% 25.00% -20.00%
1 Day -0.31% 0.00% 20.37% 25.00% -11.11%
1 Week -1.09% 0.00% 37.04% 28.57% -23.53%
2 Weeks -4.34% -5.26% 22.64% 75.00% -46.67%
1 Month -4.40% -8.88% 26.42% 100.00% -60.00%

Next earnings: July 31, 2026 (64 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan22.0%47.4%19
Feb1.2%35.0%20
Mar-5.8%20.0%20
Apr14.7%50.0%20
May-3.8%31.6%19
Jun7.8%31.6%19
Jul7.7%31.6%19
Aug-6.5%21.1%19
Sep-5.9%31.6%19
Oct-4.9%26.3%19
Nov-8.6%31.6%19
Dec2.4%36.8%19

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.21% 18.9% 914
Tuesday 0.02% 20.2% 1002
Wednesday 0.44% 19.6% 999
Thursday -0.20% 17.1% 981
Friday 0.29% 20.3% 977

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 74.4%

Insider Transactions — Smart Summary

Total insider ownership: 11.9%

Founder-led management: Neil Cashman (Chief Scientific Officer and Co-Founder)

12-Month Insider Activity Summary

Total Filings7
Net Value+$25,005.15
Net Shares Change649,539
% of Float14.1%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
ABG Management Ltd. +$8.5M 1 1 buy
Williams Eugene +$141,220 2 2 buy
Kirwin Patrick D. +$45,320 1 1 buy
Kaplan Johanne Chief Development Officer +$25,005.15 1 1 buy
Milbury Max A. +$14,928.55 1 1 buy
GORDON MICHAEL S +N/A 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-23 Kirwin Patrick D. +$45,320 Transaction at $11.33, now -7.5%
2026-03-06 Williams Eugene +$48,800 Transaction at $24.40, now -57.0%
2026-03-04 Williams Eugene +$92,420 Transaction at $23.11, now -54.6%
2026-02-23 Kaplan Johanne Chief Development Officer +$25,005.15 Transaction at $15.35, now -31.7%
2026-02-05 ABG Management Ltd. +$8.5M Transaction at $12.13, now -13.6%
2025-10-06 Milbury Max A. +$14,928.55 Transaction at $0.49, now +2033.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for ProMIS Neurosciences Inc. (PMN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for PMN on Trend Edge →